Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $1,102,466 (100.0% shares, 0.0% debt)

Holdings (7)

— NGM Biopharmaceuticals Inc 42.3%

Value ($000) $466,502 Shares 15,396,116 Est. Cost $30.30 Unrealized —

NRIX Nurix Therapeutics Inc 16.1%

Value ($000) $177,004 Shares 5,383,333 Est. Cost $33.14 Unrealized 0.0%

ORIC ORIC Pharmaceuticals Inc. 14.6%

Value ($000) $161,403 Shares 4,768,181 Est. Cost $28.69 Unrealized 0.0%

RVMD Revolution Medicines Inc 12.9%

Value ($000) $141,742 Shares 3,580,252 Est. Cost $39.54 Unrealized 0.0%

— RAPT Therapeutics Inc 7.0%

Value ($000) $76,742 Shares 3,885,679 Est. Cost $19.75 Unrealized —

— Constellation Pharmaceuticals Inc. 6.9%

Value ($000) $75,647 Shares 2,626,631 Est. Cost $28.80 Unrealized —

— Gritstone Oncology Inc 0.3%

Value ($000) $3,426 Shares 869,493 Est. Cost $3.94 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	NGM Biopharmaceuticals Inc	15,396,116	$466,502	42.3%	$30.30	—	COM	62921N105
NRIX	Nurix Therapeutics Inc	5,383,333	$177,004	16.1%	$33.14	0.0%	COM	67080M103
ORIC	ORIC Pharmaceuticals Inc.	4,768,181	$161,403	14.6%	$28.69	0.0%	COM	68622P109
RVMD	Revolution Medicines Inc	3,580,252	$141,742	12.9%	$39.54	0.0%	COM	76155X100
—	RAPT Therapeutics Inc	3,885,679	$76,742	7.0%	$19.75	—	COM	75382E109
—	Constellation Pharmaceuticals Inc.	2,626,631	$75,647	6.9%	$28.80	—	COM	210373106
—	Gritstone Oncology Inc	869,493	$3,426	0.3%	$3.94	—	COM	39868T105